semaglutide and general anesthesia Stopping GLP-1 Prior to Surgery: UK Perioperative Guidance – Bolt Pharmacy semaglutide and general anesthesia A

AstraZeneca: Byetta (exenatide) and Bydureon (exenatide extended-release): Older GLP-1 RAs

These benefits occurred alongside a modest weight loss of 2.2 pounds (1 kg), suggesting that these improvements were largely independent of body weight

nAMD Symptoms May Include: Distortion of straight lines (metamorphopsia) Blurred or fuzzy central vision Dark or empty areas in the center of vision Difficulty seeing fine detail, even with glasses Sudden worsening of visual acuity The aggressive nature of nAMD means early detection plays a key role in preventing permanent vision loss

Comprehensive medical assessment is essential before initiating weight loss injection therapy, particularly for patients with known or suspected fatty liver disease